Under the DELIVER initiative, MHRP researchers are conducting targeted technology transfer to expand HIV cure research capacity. Early efforts focus on transferring neutralization, pharmacokinetic (PK), and anti-drug antibody (ADA) assays to DELIVER partner sites, beginning in Tanzania and Thailand. By decentralizing these processes, DELIVER is strengthening local research infrastructure and advancing HIV research capabilities at a network of sites through Africa, Asia and South America.
MHRP and a global network of partners initiated the Developing Leadership and Innovation in Viral Eradication Research (DELIVER) initiative; an ambitious initiative to advance and harmonize HIV cure research around the world.
An ongoing Phase 1 human trial in Tanzania is evaluating the safety and antiviral activity of a novel bispecific antibody, alone and in combination with another potent monoclonal antibody, to combat HIV.
Mentor Mothers, like Sarah Mwakajinga, play a vital role in the Prevention of Mother-to-Child Transmission (PMTCT) program. Sarah was introduced to Salome early in her journey and has been by her side ever since.
In the remote fishing hamlet of Ilanga Village Camp, nestled along the shores of Lake Rukwa in southwestern Tanzania, people living with HIV (PLHIV) have long faced significant barriers to consistent treatment. As a community volunteer, Lucia—known affectionately as Lucy—became a trusted lifeline for her fellow villagers, especially those too isolated, mobile, or hesitant to seek care.
